[Excerpt from article by Amy Kapczynski in the New England Journal of Medicine] India is known as the “pharmacy of the developing world,” because it supplies much of the world’s demand for affordable, generic drugs. So when the Supreme Court of India issued a landmark ruling in April adopting a strict interpretation of the country’s new patent law, advocates for global access to medicines celebrated. In fact, the decision in Novartis v. Union of India & Others provides an important model for other countries around the world — a step toward a “patent law 2.0” that not only helps to ensure access to medicines but might also help better align pharmaceutical innovation with public health needs.
Click here for the full article on the NEJM website.
QUT Media4th November 2025 The United Kingdom Parliament is considering a bill aimed at making smoking obsolete, which has been
Speaking at the Global Expert Network on Copyright User Rights Symposium on 16 June 2025, Professor Christophe Geiger argues for
On 25 September 2025, Professor Wend Wendland, delivered the 14th Peter Jaszi Distinguished Lecture at American University in Washington D.C..
On September 18, 2025, the Italian Senate definitively approved the country’s first comprehensive framework law on artificial intelligence (AI). The
Por Andrés Izquierdo Durante la segunda semana de agosto, fui invitado a hablar en la Feria Internacional del Libro de
By Andrés Izquierdo AI, Copyright, and the Future of Creativity: Notes from the Panama International Book FairDuring the second week